key: cord-0007809-myrqlrb9
authors: Mucke, L.; Oldstone, M.B.A.
title: The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV)
date: 2002-11-13
journal: J Neuroimmunol
DOI: 10.1016/0165-5728(92)90050-u
sha: 797d4bc91a5889c5fbcd4a51cbd1459fe277fe58
doc_id: 7809
cord_uid: myrqlrb9

Intracranial inoculation of immunocompetent mice with lymphocytic choriomeningitis virus (LCMV) induces a fatal neurologic illness. In this disease a marked increase in MHC class I expression was found, closely associated with viral antigens and inflammatory infiltrates, in meninges, choroid plexus and ventricular ependyma but not within the brain parenchyma. Immunosuppression prevented MHC induction. Mice inoculated at birth had persistent infections, with LCMV antigens found primarily in neurons, but no inflammatory cells or focal increase in MHC class I. Failure of infected neurons to express MHC class I allow them to escape destruction by cytotoxic T cells (CTL) but may increase their susceptibility to be persistently infected by non-lytic viruses.

Infections of mice with lymphocytic choriomeningitis virus (LCMV) provide useful models for virus-induced neurologic disease (Buchmeier et al., 1980; Lehmann-Grube, 1984; Oldstone et al., 1985 Oldstone et al., , 1986 . In immunocompetent mice, intracranial inoculation of LCMV leads to an acute fatal neurologic illness which is dependent on LCMV-specific cytotoxic T cells (CTL) (Cole et Correspondence to: L. Mucke, Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA. al., 1972; Zinkernagel and Doherty, 1973; Dixon et al., 1987; Klavinskis et al., 1989) . Inoculation of LCMV into neonatal or immunosuppressed mice, on the other hand, establishes a persistent infection in which viral antigens are expressed but not detected by host CTL (Hotchin and Cinits, 1958; Gilden et al., 1972; Mires and Blanden, 1972) . The recognition of viruses, such as LCMV, by CTL is critically dependent on major histocompatibility complex (MHC) class I molecules (Doherty and Zinkernagel, 1974; Doherty, 1974, 1983) . The level of MHC class I expression by infected cells correlates with the degree of effectiveness of CTL-mediated lysis (Plata et al., 1981; Flyer et al., 1985; Gairin et al., 1991; Joly et al., 1991) . While in the normal CNS only low levels of MHC class I antigens are found, MHC class I expression can be upmodufated on some brain cells by cytokines and viruses (Wong et al., 1984; Main et al., 1985; Lampson and Hickey, 1986; Suzumura et al., 1986 Suzumura et al., , 1988 Hickey and Kimura, 1987; Joly et al., 1991) . The current paper compares amount and distribution of MHC class I molecules, inflammatory infiltrates and viral antigens in brains of mice with acute and persistent LCMV infections to assess the roles of these factors in immune-mediated neurologic disease and viral persistence.

Twenty-four 3-to 4-month-old immunocompetent C57BL/6 (H-2 b) and C3H (H-2 k) mice were untreated or inoculated intracranially (i.c.) with 30 Ixl of: phosphate-buffered saline (PBS), or 1000 plaque-forming units (PFU) of the Armstrong CA 1371 clone 53B of LCMV (Dutko and Oldstone, 1983) in medium or LCMV inactivated by ultraviolet (UV) irradiation and heating. Total body irradiation (900 rads) from a cobalt source given just before i.c. inoculations was used to suppress CTL responses in eight C57BL/6 mice. Each experimental paradigm was tested on groups of 3-4 mice. Typical signs of acute LCMV infection developed in non-irradiated mice inoculated with live virus after 5-6 days whereas none of the other mice showed signs of illness. All mice were killed 6-7 days after the acute i.c. inoculations together with three age-matched C57BL/6 mice persistently infected with LCMV by i.c. inoculation at birth (Oldstone et al., 1986) . Serial cryostat-cut sections of snap-frozen brains (10 txm) were air-dried at room temperature (RT) for 1 h, fixed in ice-cold acetone for 10 min and stored at 4°C overnight. Subsequent incubations and washes were carried out at RT in 2% fetal bovine serum/1 × PBS (pH 7.3). After 30 rain of incubation in buffer alone sections were incubated with primary antibodies for 2 h: mouse monoclonal antibody (mAb) B22-249. R1 directed against D b (Lemke et al., 1979 ) (dilution 1 : 50) or mouse mAb 1-1.3 specific for LCMV nucleoprotein (Buchmeier et al., 1981) (dilution 1:100). This was followed by a 1 h incubation with peroxidase-coupled sheep anti-mouse IgG2a secondary antibodies (Bioproducts for Science, Indianapolis, IN, USA) at a 1:200 dilution. Sections were developed with HzOz/diaminobenzidine (DAB) for 10-15 min and counterstained with hematoxylin and eosin.

In unmanipulated and sham-injected (uninfected) C57BL/6 mice (H-2 b) only low levels of MHC class I were identified in restricted brain regions. Specifically, faint immunostaining of cell surfaces for D b was seen in choroid plexus, meninges and blood vessel walls but not on neurons, astrocytes, oligodendrocytes or microglia. No inflammatory infiltrates or immunostaining for LCMV antigens were found in the brains of control animals. Mice infected acutely by i.c. inoculation with LCMV showed dense inflammatory infiltrates of the meninges ( Fig. 1A and C) . Inflammatory cells were also seen along the ependymal lining of the ventricles and around the choroid plexus. The brain parenchyma showed no obvious abnormalities. Viral antigens were identified in the choroid plexus, the meninges, the ependymal epithelium and in some of the inflammatory cells that infiltrated these structures (Fig.  1B) . These findings are all consistent with previous observations (Gilden et al., 1972; Walker et al., 1975; Doyle and Oldstone, 1978) .

Immunostaining for D b in the acute infection revealed a substantial increase in the expression of MHC class I over control levels in specific sites. Intense O b expression was found in choroid plexus, meninges and ventricular ependyma as well as on the cells that comprised the inflammatory infiltrates whereas no increase in MHC class I expression was found within the brain parenchyma ( Fig. IC and D) . In some areas a close topologic overlap was documented between the expression of viral antigens and host MHC class I molecules in adjacent sections ( Fig. 1B  and D) .

Total body irradiation prevented the marked increase in MHC class I expression, the neurologic illness and the inflammatory infiltrates that were seen in acutely infected immunocompetent mice whereas the amount of viral antigen in irradiated and non-irradiated mice was similar (Table 1 ). This suggests that the upmodulation of MHC class I by acutely infected host cells is induced primarily by the cellular immune response rather than directly by the LCMV infection itself. It is tempting to speculate that the increased MHC class I expression is mediated by cytokines released from infiltrating immune cells.

The increased expression of MHC molecules by acutely infected cells would be expected to enhance their interaction with immune cells and may contribute to the immunopathology. In brains of mice persistently infected with LCMV no inflammatory cells were found despite the presence of LCMV antigens in most brain regions. Consistent with previous observations (Buchmeier et al., 1980; Rodriguez et al., 1983) LCMV antigens were seen primarily in cells with neuronal morphology. In some cases LCMV antigen was also found in cells of the choroid plexus and the ventricular ependyma confirming earlier results (Gilden et al., 1972; Lampert and Oldstone, 1974; Fazakerley et al., 1991) . In contrast to the acute infection, in which LCMV antigens co-localized with upmodulation of D b, the presence of LCMV antigens was not accompanied by focal increases in the expression of host MHC class I molecules ( Fig. 1E and F) .

LCMV can be cleared from the brain parenchyma of persistently infected mice by adoptive transfer of LCMV-specific CTL from immunocompetent H-2 matched donors (Oldstone et al., 1986) . However, this clearance is not accompanied by inflammatory infiltrates and there is no evidence that LCMV-infected neurons can be lysed by LCMV-specific CTL in vivo (Klavinskis et al., 1989; Joly et al., 1991) . In vitro LCMV-infected neuronal cells can be lysed by LCMV-specific CTL but only after treatment with interferon-y or following expression of exogenous MHC class I . Our current results suggest that LCMV infection by itself does not induce detectable MHC class I expression on neuronal cells in vivo. Why LCMV-infected neurons fail to express MHC class I molecules in vivo is unclear. While activated T cells are able to traverse the blood-brain barrier (Wekerle et al., 1986 (Wekerle et al., , 1987 they may not be able to interact with infected neurons in sufficient numbers because of the relatively sheltered location of neurons within the neuropil. It is also possible that other brain cells, such as astrocytes, produce factors that interfere with MHC induction on neurons. Further, differentiated neurons in vivo may be inherently unable to express MHC class I at significant levels as suggested by recent studies on cultured neuronal cells . This may provide a selective advantage by excluding these irreplaceable cells from destruction by CTL. The escape of neurons from CTL surveillance would, however, also allow non-lyric viruses to persist in neurons over the animal's life span. Results reflect immunocytochemical findings in brain sections from 3-month-old female C57BL/6 mice (n = 4/group for Nos. 1-3; n-3/group for No. 4). (+) Dense immunostaining by peroxidase reaction (see brown labeling in Fig. 1B-E) . (-) No immunostaining above background levels (see Fig. 1A and F). Groups 1-3 were acutely inoculated as adults whereas group 4 was persistently infected at birth. Mice were killed for histologic analysis 7 days after the acute i.c. inoculations. At this time all mice in group 1 were ill, whereas all the other mice appeared normal. 

The virology and immunobiology of lymphocytic choriomeningitis virus infection

Mouoclonal antibodies to lymphocytic choriomeningitis and Pichinde viruses: generation, characterization and cross-reactivity with other arenaviruses. Virology

Requirement for 0-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease

The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2 + immune T cells

T-cell-mediated immunopathology in viral infections

Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus during both chronic and acute viral infections

Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains

High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence

Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes

Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I glycoprotein on cultured mouse brain endothelial cells

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction of the virus carrier-state in adult mice

Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigen and the presence of scattered T lymphocytes in rat central nervous system

Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection

Viral persistence in neurons can be explained by a lack of MHC class 1 expression

Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo

Pathology of the choroid plexus in spontaneous immune complex disease and chronic viral infections

Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from 'histologically normal' to that showing different levels of glial tumor involvement

Portraits of viruses: arenaviruses

Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice

Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes

Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus

Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis

Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system

Quantitative variations in the expression of H-2 antigens on murine leukemia virus-infected tumor cells can affect the H-2-restriction patterns of tumor-specific cytolytic T lymphocytes

Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV)

Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes

Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells

Lymphocytic choriomeningitis: uttrastructural pathology

Cellular immune reactivity within the CNS

Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells

Inducible expression of H-2 and la antigens on brain cells

Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis

Restriction of in vitro T cell mediated eytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system

MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function, and responsiveness

We thank Antoinette Tishon for assisting with i.c. inoculations, Gay Schilling for helping prepare and Glenn Rall for reviewing the manuscript. This work was supported by NIH grant P50-MHA47680-01, AI-09484, AG-04342 and NS-12428. L. Mucke is also supported by Faculty Scholarships from the Alzheimer's Association and the National Multiple Sclerosis Society.